ArriVent BioPharma, Inc. Common StockAVBPNASDAQ
LOADING
|||
EBITDA Over Time
Below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-80.49M
↓ 56% below average
Average (3y)
$-51.67M
Historical baseline
Range
High:$0.00
Low:$-80.49M
CAGR
+16.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-80.49M | -7.9% |
| 2023 | $-74.59M | - |
| 2022 | $0.00 | +100.0% |
| 2021 | $-51.61M | - |